<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2017, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 21 Sep 2016 08:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</guid>
   <pubDate>Wed, 21 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06761543</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</guid>
   <pubDate>Wed, 21 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06761543</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</guid>
   <pubDate>Wed, 21 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06761543</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 2016 Aegis Capital Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+2016+Aegis+Capital+Conference/12057613.html</guid>
   <pubDate>Wed, 21 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06761543</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development</title>
   <link>http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:32:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development</title>
   <link>http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:32:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development</title>
   <link>http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:32:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Unit Receives Additional USAMRMC Funding for CMHA-S Development</title>
   <link>http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Unit+Receives+Additional+USAMRMC+Funding+for+CMHA-S+Development/12026299.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:32:20 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19894622</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19894622</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19894622</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Awarded $448,185 for second year of funding of Phase II SBIR Grant from U.S. Department of Defense</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Awarded+%24448%2C185+for+second+year+of+funding+of+Phase+II+SBIR+Grant+from+U.S.+Department+of+Defense/12026251.html</guid>
   <pubDate>Tue, 13 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19894622</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.40958841</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License</title>
   <link>http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:34:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License</title>
   <link>http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:34:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License</title>
   <link>http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:34:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License</title>
   <link>http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:34:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License</title>
   <link>http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:34:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
   	  </item>
  <item>
   <title>Eyegate Pharma (EYEG) Announces Receipt of Additional Milestone Payment from Valeant (VRX) Related to EGP-437 License</title>
   <link>http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eyegate+Pharma+%28EYEG%29+Announces+Receipt+of+Additional+Milestone+Payment+from+Valeant+%28VRX%29+Related+to+EGP-437+License/12021903.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:34:22 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VRX</category>
   	  </item>
  <item>
   <title>EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Receives+Additional+Milestone+Payment+from+Valeant+Pharmaceuticals+for+EGP-437/12021834.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Receives+Additional+Milestone+Payment+from+Valeant+Pharmaceuticals+for+EGP-437/12021834.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Receives+Additional+Milestone+Payment+from+Valeant+Pharmaceuticals+for+EGP-437/12021834.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Receives Additional Milestone Payment from Valeant Pharmaceuticals for EGP-437</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Receives+Additional+Milestone+Payment+from+Valeant+Pharmaceuticals+for+EGP-437/12021834.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Receives+Additional+Milestone+Payment+from+Valeant+Pharmaceuticals+for+EGP-437/12021834.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Receives+Additional+Milestone+Payment+from+Valeant+Pharmaceuticals+for+EGP-437/12021834.html</guid>
   <pubDate>Mon, 12 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html</guid>
   <pubDate>Tue, 06 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html</guid>
   <pubDate>Tue, 06 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals to Present at the 18th Annual Rodman and Renshaw Global Investment Conference</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+to+Present+at+the+18th+Annual+Rodman+and+Renshaw+Global+Investment+Conference/12003065.html</guid>
   <pubDate>Tue, 06 Sep 2016 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.42710185</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Second+Quarter+2016+Financial+Results+and+Provides+Business+Update/11926366.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Second+Quarter+2016+Financial+Results+and+Provides+Business+Update/11926366.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Second+Quarter+2016+Financial+Results+and+Provides+Business+Update/11926366.html</guid>
   <pubDate>Wed, 10 Aug 2016 16:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19894622</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
  <item>
   <title>EyeGate Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Second+Quarter+2016+Financial+Results+and+Provides+Business+Update/11926366.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Second+Quarter+2016+Financial+Results+and+Provides+Business+Update/11926366.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/EyeGate+Pharmaceuticals+Reports+Second+Quarter+2016+Financial+Results+and+Provides+Business+Update/11926366.html</guid>
   <pubDate>Wed, 10 Aug 2016 16:50:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.19894622</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEG</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">EYEGW</category>
   	  </item>
 </channel>
</rss>
